|
1
|
Mowery NT, Terzian WT and Nelson AC: Acute
lung injury. Curr Probl Surg. 57:1007772020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuldanek SA, Kelher M and Silliman CC:
Risk factors, management and prevention of transfusion-related
acute lung injury: A comprehensive update. Expert Rev Hematol.
12:773–785. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Semple JW, McVey MJ, Kim M, Rebetz J,
Kuebler WM and Kapur R: Targeting transfusion-related acute lung
injury: The journey from basic science to novel therapies. Crit
Care Med. 46:e452–e458. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leite LFB, Máximo TA, Mosca T and Forte
WCN: CD40 ligand deficiency. Allergol Immunopathol (Madr).
48:409–413. 2020. View Article : Google Scholar
|
|
5
|
França TT, Barreiros LA, Al-Ramadi BK,
Ochs HD, Cabral-Marques O and Condino-Neto A: CD40 ligand
deficiency: Treatment strategies and novel therapeutic
perspectives. Expert Rev Clin Immunol. 15:529–540. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dasgupta S, Dasgupta S and Bandyopadhyay
M: Regulatory B cells in infection, inflammation, and autoimmunity.
Cell Immunol. 352:1040762020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Subauste CS: The CD40-ATP-P2X7
receptor pathway: Cell to cell cross-talk to promote inflammation
and programmed cell death of endothelial cells. Front Immunol.
10:29582019. View Article : Google Scholar
|
|
8
|
Fujihara C, Kanai Y, Masumoto R, Kitagaki
J, Matsumoto M, Yamada S, Kajikawa T and Murakami S: Fibroblast
growth factor-2 inhibits CD40-mediated periodontal inflammation. J
Cell Physiol. 234:7149–7160. 2019. View Article : Google Scholar
|
|
9
|
Seigner J, Basilio J, Resch U and de
Martin R: CD40L and TNF both activate the classical NF-κB pathway,
which is not required for the CD40L induced alternative pathway in
endothelial cells. Biochem Biophys Res Commun. 495:1389–1394. 2018.
View Article : Google Scholar
|
|
10
|
Woolaver RA, Wang X, Dollin Y, Xie P, Wang
JH and Chen Z: TRAF2 deficiency in B cells impairs CD40-Induced
isotype switching that can be rescued by restoring NF-κB1
activation. J Immunol. 201:3421–3430. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mulero MC, Huxford T and Ghosh G:
NF-kappaB, IkappaB, and IKK: Integral components of immune system
signaling. Adv Exp Med Biol. 1172:207–226. 2019. View Article : Google Scholar
|
|
12
|
Durand JK and Baldwin AS: Targeting IKK
and NF-κB for therapy. Adv Protein Chem Struct Biol. 107:77–115.
2017. View Article : Google Scholar
|
|
13
|
Pordanjani SM and Hosseinimehr SJ: The
role of NF-κB inhibitors in cell response to radiation. Curr Med
Chem. 23:3951–3963. 2016. View Article : Google Scholar
|
|
14
|
Scott O and Roifman CM: NF-κB pathway and
the goldilocks principle: Lessons from human disorders of immunity
and inflammation. J Allergy Clin Immunol. 143:1688–1701. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kellner M, Noonepalle S, Lu Q, Srivastava
A, Zemskov E and Black SM: ROS signaling in the pathogenesis of
acute lung injury (ALI) and acute respiratory distress syndrome
(ARDS). Adv Exp Med Biol. 967:105–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ward PA, Fattahi F and Bosmann M: New
insights into molecular mechanisms of immune complex-induced injury
in lung. Front Immunol. 7:862016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang J, Wang Z, Wang P and Wang M:
Extraction, structure and bioactivities of the polysaccharides from
Ginkgo biloba: A review. Int J Biol Macromol. 62:1897–1905. 2020.
View Article : Google Scholar
|
|
18
|
Zhang R, Han D, Li Z, Shen C, Zhang Y, Li
J, Yan G, Li S, Hu B, Li J and Liu P: Ginkgolide C alleviates
myocardial ischemia/reperfusion-induced inflammatory injury via
inhibition of CD40-NF-κB pathway. Front Pharmacol. 9:1092018.
View Article : Google Scholar
|
|
19
|
Su X, Wang L, Song Y and Bai C: Inhibition
of inflammatory responses by ambroxol, a mucolytic agent, in a
murine model of acute lung injury induced by lipopolysaccharide.
Intensive Care Med. 30:133–140. 2004. View Article : Google Scholar
|
|
20
|
McGuigan RM, Mullenix P, Norlund LL, Ward
D, Walts M and Azarow K: Acute lung injury using oleic acid in the
laboratory rat: Establishment of a working model and evidence
against free radicals in the acute phase. Curr Surg. 60:412–417.
2003. View Article : Google Scholar
|
|
21
|
Chopra M, Reuben JS and Sharma AC: Acute
lung injury: Apoptosis and signaling mechanisms. Exp Biol Med
(Maywood). 234:361–371. 2009. View Article : Google Scholar
|
|
22
|
Zhao F, Shi D, Li T, Li L and Zhao M:
Silymarin attenuates paraquat-induced lung injury via Nrf2-mediated
pathway in vivo and in vitro. Clin Exp Pharmacol Physiol.
42:988–998. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toumpanakis D, Vassilakopoulou V, Sigala
I, Zacharatos P, Vraila I, Karavana V, Theocharis S and
Vassilakopoulos T: The role of Src and ERK1/2 kinases in
inspiratory resistive breathing induced acute lung injury and
inflammation. Respir Res. 18:2092017. View Article : Google Scholar
|
|
24
|
Gouda MM and Bhandary YP: Acute lung
injury: IL-17A-mediated inflammatory pathway and its regulation by
curcumin. Inflammation. 42:1160–1169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Omidkhoda SF, Razavi BM and Hosseinzadeh
H: Protective effects of Ginkgo biloba L. against natural toxins,
chemical toxicities, and radiation: A comprehensive review.
Phytother Res. 33:2821–2840. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dubey AK, Shankar PR, Upadhyaya D and
Deshpande VY: Ginkgo biloba-an appraisal. Kathmandu Univ Med J
(KUMJ). 2:225–229. 2004.
|
|
27
|
Boxio R, Wartelle J, Nawrocki-Raby B,
Lagrange B, Malleret L, Hirche T, Taggart C, Pacheco Y, Devouassoux
G and Bentaher A: Neutrophil elastase cleaves epithelial cadherin
in acutely injured lung epithelium. Respir Res. 17:1292016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao H, Chen H, Xiaoyin M, Yang G, Hu Y,
Xie K and Yu Y: Autophagy activation improves lung injury and
inflammation in sepsis. Inflammation. 42:426–439. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Masuda H, Mori M, Umehara K, Furihata T,
Uchida T, Uzawa A and Kuwabara S: Soluble CD40 ligand disrupts the
blood-brain barrier and exacerbates inflammation in experimental
autoimmune encephalomyelitis. J Neuroimmunol. 316:117–120. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takada YK, Yu J, Shimoda M and Takada Y:
Integrin binding to the trimeric interface of CD40L plays a
critical role in CD40/CD40L signaling. J Immunol. 203:1383–1391.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu ZL, Hu J, Xiao XF, Peng Y, Zhao SP,
Xiao XZ and Yang MS: The CD40 rs1883832 polymorphism affects sepsis
susceptibility and sCD40L levels. Biomed Res Int.
2018:74973142018.
|
|
32
|
Bishop GA, Stunz LL and Hostager BS: TRAF3
as a multifaceted regulator of B lymphocyte survival and
activation. Front Immunol. 9:21612018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu N, Lambert S, Bornstein J, Nair RP,
Enerbäck C and Elder JT: The Act1 D10N missense variant impairs
CD40 signaling in human B-cells. Genes Immun. 20:23–31. 2019.
View Article : Google Scholar
|
|
34
|
Pan WZ, Du J, Zhang LY and Ma JH: The
roles of NF-κB in the development of lung injury after one-lung
ventilation. Eur Rev Med Pharmacol Sci. 22:7414–7422.
2018.PubMed/NCBI
|
|
35
|
Ulivi V, Giannoni P, Gentili C, Cancedda R
and Descalzi F: p38/NF-κB-dependent expression of COX-2 during
differentiation and inflammatory response of chondrocytes. J Cell
Biochem. 104:1393–1406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yin HC, Liu XY, Liu PM, Zhang H, Liang P,
Wang ZL and She MP: Effect of mm-LDL on NF-κB activation in
endothelial cell. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 23:312–316.
2001.In Chinese.
|
|
37
|
Asaad NY and Sadek GS: Pulmonary
cryptosporidiosis: Role of COX2 and NF-κB. APMIS. 114:682–689.
2006. View Article : Google Scholar : PubMed/NCBI
|
